Page 18 of 20
IM3.1-22 | Pneumonia — Graded Quiz
Click any question card to reveal the correct answer.
A 70-year-old man with COPD is admitted with worsening breathlessness and productive cough. He was discharged 12 days ago after a 10-day admission for COPD exacerbation, during which he received IV co-amoxiclav. On examination: RR 32/min, SpO2 82% on room air, creatinine 1.6 mg/dL. CXR shows new right upper lobe consolidation. He is oriented but drowsy. Which pathogen profile should guide empirical antibiotic selection, and why does his recent admission change the likely organism?
Correct. This patient has community-acquired pneumonia by acquisition setting (>48 hours after the current admission, but the infection was community-acquired before presenting). However, three risk factors flag him for drug-resistant organisms within the CAP spectrum (not HAP): prior antibiotic use within 90 days (co-amoxiclav), structural lung disease (COPD), and recent hospitalisation. These increase the probability of resistant Streptococcus pneumoniae and Pseudomonas aeruginosa. The correct empirical strategy is an antipseudomonal beta-lactam (cefepime or piperacillin-tazobactam) plus a macrolide or respiratory fluoroquinolone — broader than standard CAP coverage but not full HAP coverage.
Risk factors for drug-resistant CAP pathogens: prior systemic antibiotics in last 90 days, hospitalisation in last 90 days, structural lung disease (bronchiectasis, COPD), immunosuppression. These patients need antipseudomonal coverage even within the CAP category. HAP = strictly pneumonia occurring ≥48h after the current admission.
CAP with risk factors for drug-resistant organisms (prior antibiotics, structural lung disease, recent hospitalisation) requires broadened CAP coverage including antipseudomonal activity, not standard CAP or full HAP regimens. Right upper lobe is not specific to aspiration (aspiration favours posterior segments of upper lobes or lower lobes in upright patients, but any lobe can be affected).
Click to reveal answer
A 55-year-old woman develops pneumonia 7 days after being mechanically ventilated for a drug overdose. Bronchoalveolar lavage (BAL) grows Pseudomonas aeruginosa sensitive to piperacillin-tazobactam and ceftazidime, but resistant to carbapenems, aminoglycosides, and ciprofloxacin. She is haemodynamically stable. Which treatment strategy is most appropriate?
Correct. Culture-directed therapy (IM3.16) means using sensitivity results to de-escalate or optimise therapy. This Pseudomonas strain is sensitive to piperacillin-tazobactam and ceftazidime. Piperacillin-tazobactam monotherapy is appropriate for a haemodynamically stable patient — it provides adequate coverage for a sensitive Pseudomonas without exposing the patient to broader-spectrum agents unnecessarily. Colistin is reserved for pan-resistant organisms. Vancomycin is an anti-MRSA agent and has no Gram-negative activity.
Antibiotic stewardship in VAP: always review and de-escalate at 48-72 hours once culture results are available. Use the narrowest agent that covers the identified organism. Colistin is reserved for organisms resistant to all other tested antibiotics. Duration for VAP: 7-8 days for most (14 days for non-fermenting GNRs like Pseudomonas/Acinetobacter).
Culture-directed therapy means choosing the narrowest effective agent based on sensitivity results. Piperacillin-tazobactam is active against this Pseudomonas strain. Colistin is a last resort for pan-drug-resistant Pseudomonas. Vancomycin has no Gram-negative activity.
Click to reveal answer
A 40-year-old woman presents with 5 days of cough, fever, and right-sided pleuritic chest pain. On examination: temperature 38.7°C, BP 110/70, RR 22/min, heart rate 102/min. She is not confused. CXR shows right lower lobe consolidation. Urea is 5.8 mmol/L. She is allergic to penicillin (urticaria). What is the CURB-65 score and the most appropriate antibiotic choice?
Correct. CURB-65 scoring: C=0 (not confused), U=0 (urea 5.8, not >7 mmol/L), R=0 (RR 22, not ≥30), B=0 (BP 110/70, neither systolic <90 nor diastolic ≤60), 65=0 (age 40). CURB-65 = 0 — but with HR 102 and 5 days of symptoms, outpatient oral therapy is appropriate with a lower threshold to review. Penicillin allergy type: urticaria = non-anaphylactic; cross-reactivity with cephalosporins is <2% (not an absolute contraindication for cephalosporins). However, the safest and clearest choice is a respiratory fluoroquinolone (levofloxacin) or doxycycline — both avoid beta-lactams entirely and both cover CAP pathogens including atypicals.
Penicillin allergy risk stratification: anaphylaxis/angioedema = avoid all beta-lactams (use levofloxacin/doxycycline); urticaria/rash = avoid penicillins, cephalosporins can be used with caution. CURB-65 0: low risk, outpatient oral treatment appropriate.
CURB-65 = 0 (no confusion, urea 5.8 not >7, RR 22 not ≥30, BP 110/70 not hypotensive, age 40 not ≥65). Penicillin urticaria (non-anaphylactic): avoid penicillins; cephalosporins can be used cautiously (cross-reactivity <2%); levofloxacin/doxycycline are safe alternatives. Vancomycin is anti-MRSA — inappropriate for CAP without MRSA risk.
Click to reveal answer
A 62-year-old man with alcoholic liver disease (Child-Pugh C) is admitted with right lower lobe consolidation and a right pleural effusion. His CURB-65 is 3. On thoracentesis, pH is 7.05, glucose 1.4 mmol/L, LDH 600 U/L. Pleural fluid Gram stain shows no organisms. Over the next 48 hours, the effusion is drained via a chest tube but he develops fever spikes despite IV antibiotics. CT chest shows a multiloculated pleural collection. What is the next most appropriate step?
Correct. This is a complicated empyema with multiloculation — pleural fluid fibrin strands divide the pleural space into compartments that prevent adequate drainage through a single chest tube. The next step when a chest tube is in situ but drainage is inadequate due to loculation is intrapleural fibrinolytic therapy (streptokinase 250,000 IU or alteplase via the chest tube) — this breaks down fibrin septae and restores drainage. If fibrinolytics fail or the patient deteriorates, surgical decortication (video-assisted thoracoscopic surgery or open) is the next step. Antibiotic switching alone will not address the undrained infection.
Empyema management ladder: antibiotics + chest tube → intrapleural fibrinolytics (loculated, inadequate drainage) → surgical decortication (fibrinolytic failure). pH <7.2 or <7.0, glucose <2.2 mmol/L, positive microbiology = drain. Gram stain may be negative in 50% of empyemas — use culture and pH/glucose/LDH.
Multiloculated empyema with inadequate drainage via chest tube: intrapleural fibrinolytics (streptokinase or alteplase) break down loculations and improve drainage. Switching antibiotics without addressing the undrained collection is insufficient. Decortication is reserved for fibrinolytic failure. The fever is from the undrained infected collection, not antibiotic failure per se.
Click to reveal answer
An ABG is obtained from a 65-year-old patient admitted with severe CAP: pH 7.28, PaO2 55 mmHg, PaCO2 52 mmHg, HCO3 24 mEq/L, on 35% Venturi mask oxygen. Which acid-base disorder does this represent, and what does it indicate about respiratory reserve?
Correct. Interpretation: pH 7.28 = acidaemia. PaCO2 52 = elevated (normal 35-45) — primary respiratory acidosis. HCO3 24 = normal (no metabolic compensation yet — acute). PaO2 55 despite 35% oxygen = poor oxygenation. This is ACUTE respiratory acidosis: the normal HCO3 confirms this is acute (renal compensation takes 3-5 days to raise HCO3). Acute CO2 retention in a patient with pneumonia means the respiratory muscles cannot sustain adequate ventilation — this is ventilatory failure and an indication for NIV (BiPAP) or intubation. Expected HCO3 in acute resp acidosis: rises by 1 mEq/L for every 10 mmHg rise in PaCO2.
ABG interpretation steps: (1) pH acidaemia/alkalaemia, (2) PaCO2 respiratory contribution, (3) HCO3 metabolic contribution, (4) compensation adequacy. Acute respiratory acidosis: HCO3 rises ~1 per 10 PaCO2 rise. Chronic: HCO3 rises ~3.5 per 10 PaCO2 rise. Acute CO2 retention with pH <7.35 = indication for NIV; failing NIV = intubation.
pH 7.28 = acidosis. PaCO2 52 (elevated) = respiratory cause. HCO3 24 (normal) = no metabolic compensation yet = ACUTE. Acute respiratory acidosis + poor oxygenation despite supplemental O2 = ventilatory failure — indication for NIV/intubation. Expected HCO3 compensation in acute respiratory acidosis = 24 + (PaCO2-40)/10 = 24 + 1.2 = ~25 — so HCO3 here is just within the acute range.
Click to reveal answer
During a ward round, you review a 72-year-old patient admitted with CAP who is now on day 3 of IV ceftriaxone + IV azithromycin. Temperature has normalised, RR is 18/min, SpO2 96% on room air, she is eating, and mental status is normal. Sputum culture from day 1 shows sensitive S. pneumoniae. What is the most appropriate next step in antibiotic management?
Correct. IV-to-oral switch is appropriate when the patient meets clinical stability criteria: afebrile for 24 hours, RR <24/min, SpO2 ≥94% on room air, haemodynamically stable, alert, and tolerating oral intake. At day 3, she meets all criteria. Oral amoxicillin (or amoxicillin-clavulanate) is appropriate for confirmed sensitive S. pneumoniae. Total antibiotic duration for non-severe CAP should be 5-7 days if clinical response is good. Continuing IV therapy beyond clinical stability is not justified — it increases cost, IV-associated complications, and Clostridium difficile risk. MRSA cover is not indicated for community S. pneumoniae.
IV-to-oral switch criteria (all must be met): temperature <37.8°C for 24h, HR <100, RR <24/min, SpO2 ≥94% on room air, systolic BP >90, tolerating orals, no indication for IV. For sensitive S. pneumoniae CAP: total 5-7 days. Antibiotic stewardship: shortest effective course.
Clinical stability criteria met at day 3: afebrile, RR normal, SpO2 adequate, tolerating orals. IV-to-oral switch to amoxicillin is the correct antibiotic stewardship decision. Total treatment duration for CAP: 5-7 days (shorter if good response). Continuing unnecessary IV therapy increases cost and adverse effects without benefit.
Click to reveal answer
A 54-year-old man is admitted with fever, cough, and confusion. He recently attended an air-conditioned hotel conference in Bengaluru. Urine Legionella antigen is positive. CXR shows bilateral lower lobe consolidation. Serum sodium is 126 mEq/L. Which empirical antibiotic and any additional investigation are most appropriate?
Correct. Legionella pneumophila pneumonia (Legionnaires' disease) is confirmed by positive urine antigen. Classic features: air-conditioning/cooling tower exposure, extrapulmonary features (confusion, hyponatraemia, elevated LDH, hepatitis, diarrhoea, myalgia), bilateral consolidation. Treatment: respiratory fluoroquinolone (levofloxacin 750 mg IV OD, or moxifloxacin) or IV azithromycin — these are intracellular agents effective against Legionella. Beta-lactams alone are ineffective (Legionella is intracellular). Monitoring: LDH, liver function tests, renal function (rhabdomyolysis and AKI can occur).
Legionella clues: air-conditioning/water cooling towers + confusion + hyponatraemia + diarrhoea + high LDH + bilateral infiltrates. Diagnosis: urine antigen (serogroup 1); BAL culture on BCYE agar for other serogroups. Treatment: levofloxacin or azithromycin (intracellular-active agents); NOT beta-lactams alone. Duration: 14-21 days (immunocompromised) or 7-10 days (immunocompetent).
Legionella: intracellular organism, beta-lactams alone are ineffective. Urine antigen is diagnostic for serogroup 1 (most common). Treatment: respiratory fluoroquinolone (levofloxacin) or azithromycin. Extrapulmonary features — hyponatraemia, elevated LDH, hepatitis — should be monitored. Check LFTs, renal function, CK.
Click to reveal answer
A 78-year-old woman with ischaemic stroke (bedbound, nasogastric tube in situ) develops fever and new left lower lobe consolidation. She has no prior antibiotic exposure. Which pathogen group should empirical therapy cover, and what is the preferred antibiotic regimen?
Correct. This patient has classic risk factors for aspiration pneumonia: impaired consciousness (stroke), bedbound posture (left lower lobe is dependent), and nasogastric tube (bypasses swallowing). Aspiration pneumonia pathogens: mixed oral anaerobes (Bacteroides, Peptostreptococcus), Gram-negatives (in healthcare settings — Klebsiella, Enterobacterales), and occasionally Streptococcus. First-line: amoxicillin-clavulanate (covers anaerobes + Gram-positives + some Gram-negatives) or piperacillin-tazobactam (if HAP criteria met or prior antibiotics). Metronidazole can be added for additional anaerobic cover in severe aspiration.
Aspiration pneumonia: risk factors = impaired consciousness, dysphagia, NG tube, poor dental hygiene, alcoholism. Microbiology: community = oral anaerobes dominant; hospital = mix of anaerobes + Gram-negatives. Treatment: amoxicillin-clavulanate (mild-moderate, community) or piperacillin-tazobactam (healthcare-associated/severe). Duration: 5-7 days non-complicated; 4-6 weeks if abscess.
Aspiration pneumonia (stroke, NG tube, bedbound, lower lobe): mixed anaerobes + Gram-negatives are the primary target. Amoxicillin-clavulanate provides anaerobic and Gram-positive/negative cover. Piperacillin-tazobactam for healthcare-associated or severe cases. Standard CAP regimens miss anaerobic cover.
Click to reveal answer
A 65-year-old diabetic man receives his annual influenza vaccine. His physician recommends he also receive pneumococcal vaccination. Which of the following correctly describes the current pneumococcal vaccination recommendation for adults aged 65 and above or with high-risk conditions?
Correct. Current recommendations (ACIP/Indian guidelines): Adults aged ≥65 or high-risk (DM, CKD, COPD, asplenia, immunocompromised): if pneumococcal-vaccine naive, give PCV15 or PCV20. If PCV20 given, no further pneumococcal vaccine needed. If PCV15 given, follow with PPSV23 at ≥1 year. The principle: conjugate vaccine (PCV) given first produces a stronger T-cell-dependent immune priming and boosts memory; PPSV23 broadens serotype coverage. Annual revaccination is NOT required for pneumococcal vaccines (unlike influenza which requires annual vaccination due to antigenic drift). Diabetics are in the high-risk group for pneumococcal disease.
Pneumococcal vaccines: PCV13/PCV15/PCV20 (conjugate — T-cell dependent, memory response, fewer serotypes), PPSV23 (polysaccharide — T-cell independent, broader but no memory). Sequence: conjugate first, then PPSV23 ≥1 year later (if not using PCV20 alone). Influenza: annual due to antigenic shift/drift. Indications for both: age ≥65, DM, CKD, COPD, asplenia, immunosuppression.
Pneumococcal vaccination for adults ≥65 or high-risk (DM, CKD, COPD, immunocompromised): PCV (conjugate) given first for T-cell memory priming, then PPSV23 at ≥1 year to broaden serotype coverage. NOT the reverse order. NOT annual. Diabetics ARE in the high-risk group. Influenza requires annual vaccination; pneumococcal does not.
Click to reveal answer
A 58-year-old male patient with CAP is admitted. The treating team wants to know whether he requires isolation. He is found to have active tuberculosis co-infection with Mycobacterium tuberculosis on sputum AFB smear (3+ positive). He is sputum smear-positive and on room air in a general medical ward. What is the most appropriate isolation measure?
Correct. Tuberculosis (including drug-sensitive TB) is transmitted by airborne droplet nuclei (<5 microns) that remain suspended in the air for prolonged periods. Airborne precautions are required for ALL infectious TB: negative-pressure isolation room (or isolation with doors closed if negative pressure unavailable), N95 (FFP2) respirator for ALL staff entering the room (not surgical mask — surgical masks do not filter particles <5 microns), and a surgical mask on the patient when being transported. Standard droplet precautions are insufficient. Airborne precautions apply to TB, measles, varicella, and disseminated zoster.
Isolation categories: Airborne (droplet nuclei <5 microns, long range) — TB, measles, varicella — N95 + negative pressure. Droplet (>5 microns, <1 metre) — influenza, COVID-19, meningococcal — surgical mask at ≤1 m. Contact — MRSA, C. difficile, norovirus — gloves + gown. Standard — all patients — hand hygiene, gloves.
TB is airborne (droplet nuclei <5 microns, prolonged suspension). Requires: negative-pressure room, N95 respirator for staff, surgical mask on patient during transfer. Surgical masks do not filter aerosol particles — N95/FFP2 is mandatory. Droplet precautions are for organisms that travel >1 metre (influenza, meningococcal disease) — these require surgical masks for staff at ≤1 metre.
Click to reveal answer
A 36-year-old woman with no comorbidities is sent home with oral amoxicillin for mild CAP (CURB-65 = 0). She returns 72 hours later with persistent fever (38.9°C), worsening cough, and new confusion. SpO2 is 87% on room air. CXR now shows bilateral infiltrates with a small right pleural effusion, compared to focal right lower lobe consolidation 3 days ago. What is the most appropriate next step?
Correct. This patient has clinical deterioration at 72 hours: worsening CXR (now bilateral, with effusion), new confusion, SpO2 87% (severe hypoxaemia), persistent fever. She now meets criteria for severe CAP (CURB-65 now: C=1, B=0, U=unknown, R=unknown — minimum 1; plus bilateral infiltrates, SpO2 <90%). She requires hospital admission, IV antibiotics (IV ceftriaxone + IV azithromycin to cover both typical and atypical pathogens), diagnostic workup (blood cultures x2 before antibiotics if not yet given, pleural aspiration if effusion accessible), and supplemental oxygen. Empirical antifungal therapy is not indicated without specific risk factors or microbiological evidence.
Review empirical therapy at 48-72 hours. Failure to improve: consider wrong diagnosis, resistant organism, inadequate drug, complication (empyema, lung abscess), non-infectious cause, immunosuppression. Bilateral progression + hypoxaemia + confusion = admit urgently. Never attribute failure solely to slow response without seeking the cause.
Failure to improve at 72 hours with new bilateral infiltrates, confusion, and severe hypoxaemia = treatment failure and significant clinical deterioration. This requires admission, escalation to IV combination antibiotics, and diagnostic workup (cultures, pleural aspiration). Antifungal therapy without evidence of fungal infection is not appropriate.
Click to reveal answer